These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 14981672)
1. A new measure of prognostic separation in survival data. Royston P; Sauerbrei W Stat Med; 2004 Mar; 23(5):723-48. PubMed ID: 14981672 [TBL] [Abstract][Full Text] [Related]
2. Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer. Royston P; Parmar MK; Sylvester R Stat Med; 2004 Mar; 23(6):907-26. PubMed ID: 15027080 [TBL] [Abstract][Full Text] [Related]
4. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma. Claude L; Perol D; Ray-Coquard I; Petit T; Blay JY; Carrie C; Bachelot T Radiother Oncol; 2005 Sep; 76(3):334-9. PubMed ID: 16024123 [TBL] [Abstract][Full Text] [Related]
5. Methods for categorizing a prognostic variable in a multivariable setting. Mazumdar M; Smith A; Bacik J Stat Med; 2003 Feb; 22(4):559-71. PubMed ID: 12590414 [TBL] [Abstract][Full Text] [Related]
6. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data. Chau I; Norman AR; Cunningham D; Waters JS; Oates J; Ross PJ J Clin Oncol; 2004 Jun; 22(12):2395-403. PubMed ID: 15197201 [TBL] [Abstract][Full Text] [Related]
8. A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials. Royston P; Sauerbrei W Stat Med; 2004 Aug; 23(16):2509-25. PubMed ID: 15287081 [TBL] [Abstract][Full Text] [Related]
9. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis. Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI Breast J; 2006; 12(1):37-47. PubMed ID: 16409585 [TBL] [Abstract][Full Text] [Related]
10. Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors. Nisticò C; Cuppone F; Bria E; Fornier M; Giannarelli D; Mottolese M; Novelli F; Natoli G; Cognetti F; Terzoli E Anticancer Drugs; 2006 Nov; 17(10):1193-200. PubMed ID: 17075319 [TBL] [Abstract][Full Text] [Related]
11. Joint models for multivariate longitudinal and multivariate survival data. Chi YY; Ibrahim JG Biometrics; 2006 Jun; 62(2):432-45. PubMed ID: 16918907 [TBL] [Abstract][Full Text] [Related]
12. Logical analysis of survival data: prognostic survival models by detecting high-degree interactions in right-censored data. Kronek LP; Reddy A Bioinformatics; 2008 Aug; 24(16):i248-53. PubMed ID: 18689833 [TBL] [Abstract][Full Text] [Related]
13. Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients. Cheng SH; Horng CF; Clarke JL; Tsou MH; Tsai SY; Chen CM; Jian JJ; Liu MC; West M; Huang AT; Prosnitz LR Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1401-9. PubMed ID: 16472935 [TBL] [Abstract][Full Text] [Related]
14. Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy. Dehing-Oberije C; Yu S; De Ruysscher D; Meersschout S; Van Beek K; Lievens Y; Van Meerbeeck J; De Neve W; Rao B; van der Weide H; Lambin P Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):355-62. PubMed ID: 19095367 [TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases]. Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086 [TBL] [Abstract][Full Text] [Related]
16. [Prognostic studies in cancer of the breast: optimal use of current statistical tools]. Bonichon F Bull Cancer; 1996 Dec; 83(12):1046-52. PubMed ID: 9116374 [No Abstract] [Full Text] [Related]
17. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study. Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study. Mauer ME; Taphoorn MJ; Bottomley A; Coens C; Efficace F; Sanson M; Brandes AA; van der Rijt CC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ; J Clin Oncol; 2007 Dec; 25(36):5731-7. PubMed ID: 18089867 [TBL] [Abstract][Full Text] [Related]
19. Validation of prognostic models among patients with advanced heart failure. Frankel DS; Piette JD; Jessup M; Craig K; Pickering F; Goldberg LR J Card Fail; 2006 Aug; 12(6):430-8. PubMed ID: 16911909 [TBL] [Abstract][Full Text] [Related]
20. Modelling clustered survival data from multicentre clinical trials. Glidden DV; Vittinghoff E Stat Med; 2004 Feb; 23(3):369-88. PubMed ID: 14748034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]